REVA Medical, Inc.
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $17,000 | — | — | — | — | — |
| Operating income | −$6.1M | −$7.5M | −$24.0M | −$22.0M | −$27.9M | −$5.7M |
| Net income | $1.4M | −$40.8M | −$82.6M | −$51.0M | −$27.9M | −$5.7M |
| Total assets | $22.7M | $9.5M | $20.1M | $30.2M | $24.8M | $47.4M |
| Total liabilities | $115.5M | $99.1M | $100.6M | $56.6M | $4.0M | $2.8M |
| Equity | −$92.8M | −$89.6M | −$80.6M | −$26.4M | $20.8M | $44.6M |
| EPS (diluted) | $-0.11 | $-1.01 | $-2.38 | — | — | — |
| Shares out. | 42.9M | 42.5M | 33.6M | 33.5M | 33.2M | 33.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −35682.4%
- Net margin
- 8376.5%
- Return on equity
- −1.5%
- Return on assets
- 6.3%
- Return on capital (ROCE)
- −30.3%
- Liabilities / assets
- 509.6%
- Debt / equity
- —
- Book value / share
- $-2.17
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- -52.27distress
- Accruals / assets
- 89.5%high accruals
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 0 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Other material eventMar 5, 2020
- Entered a material agreement · Bankruptcy or receivershipJan 15, 2020
- Other material eventDec 13, 2019
- Entered a material agreement · New financial obligation · Other material eventAug 7, 2019
- Entered a material agreement · New financial obligation · Other material eventApr 8, 2019
- Director / officer change · Other material eventApr 1, 2019
- Other material eventMar 13, 2019
- Other material eventMar 6, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFILING REVA MEDICAL, INC.Jan 8, 2021
- 15-12GMar 5, 2020
- 8-KMar 5, 2020
- S-8 POSMar 3, 2020
- S-8 POSMar 3, 2020
- S-8 POSMar 3, 2020
- S-8 POSMar 3, 2020
- S-8 POSMar 3, 2020
- S-8 POSMar 3, 2020
- S-8 POSMar 3, 2020
- S-8 POSMar 3, 2020
- SC 13G/AFILING REVA MEDICAL, INC.Jan 31, 2020
- 8-KJan 15, 2020
- 8-KDec 13, 2019
- 4FORM 4 SUBMISSIONNov 14, 2019
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.